Geographical variability in dabigatran dosing within New Zealand
Internal Medicine Journal · 2026-08 · 56 (8) · 1433-1437
DOI: 10.1111/imj.70477 ↗Kurz gefasst
Fachartikel in der Zeitschrift Internal Medicine Journal, online erschienen am 25.05.2026. Verfasst von Liam T Berryman und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, University of Otago, Christchurch, New Zealand. Hauptthemen laut MEDLINE: Dabigatran, Antithrombins. Die Arbeit nennt 20 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: University of Otago Future Health Researcher Scholarship, Canterbury Medical Research Foundation.
Abstract (Originalsprache)
Dabigatran etexilate is an oral anticoagulant with increased risk of bleeding at high drug exposure. It is available in three capsule strengths (75, 110 and 150 mg). We analysed New Zealand dispensing data from 2019 to 2023 to compare use between health districts. Overall use was similar across districts. Canterbury had the highest 75 mg use (22.2 vs 1.6–7.6 people per 10 000 in the other districts). This relates to differences in local guidelines, therapeutic drug monitoring and availability of clinical pharmacology services. It is unknown if there are differences in patient outcomes.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Medicine, University of Otago, Christchurch, New Zealand.
- Department of Clinical Pharmacology, Health New Zealand, Christchurch, New Zealand.
ORCID-Profile: Liam T Berryman, Paul K L Chin, Lorna J Pairman
Förderung
- University of Otago Future Health Researcher Scholarship
- Canterbury Medical Research Foundation
Zitieren
APA
Berryman, L. T., Chin, P. K. L., Pairman, L. J., Sundermann, M., & Doogue, M. (2026). Geographical variability in dabigatran dosing within New Zealand. Internal Medicine Journal, 56(8), 1433-1437. https://doi.org/10.1111/imj.70477
Vancouver
Berryman LT, Chin PKL, Pairman LJ, Sundermann M, Doogue M. Geographical variability in dabigatran dosing within New Zealand. Internal Medicine Journal. 2026;56(8):1433-1437. doi:10.1111/imj.70477
BibTeX
@article{Berryman2026,
author = {Berryman, Liam T and Chin, Paul K L and Pairman, Lorna J and Sundermann, Milan and Doogue, Matthew},
title = {Geographical variability in dabigatran dosing within New Zealand},
journal = {Internal Medicine Journal},
year = {2026},
volume = {56},
number = {8},
pages = {1433--1437},
doi = {10.1111/imj.70477}
}
EUVIMED